Dee Sparacio
womenofteal.bsky.social
Dee Sparacio
@womenofteal.bsky.social
Ovarian Cancer Survivor , cancer research advocate, #GYNCSM community cofounder , blogger
Pinned
Pls share
NJ Cancer survivors/caregivers:
Members of the NJ Cancer Control Survivorship Workgroup want to understand the everyday needs of cancer survivors in New Jersey. Help us plan future programs by completing this anonymous survey.
healthsurveys.nj.gov/NoviSurvey/n/z
Reposted by Dee Sparacio
"Findings demonstrate #ctDNA is a promising biomarker 2 complement existng monitorng approachs 4 recurrent #ovariancancer, in some cases capable of predictng relapse & treatmnt response ahead of currnt clinical indicators. Identified discordances underscore ..." 1/2 #CanSky @womenofteal.bsky.social
Dynamic Monitoring of Recurrent Ovarian Cancer Using Serial ctDNA: A Real-World Case Series - PubMed
Recurrent ovarian cancer (OC) is challenging to detect early using current methods like CA-125 and imaging. Circulating tumor DNA (ctDNA) may improve disease monitoring. Here, we assess the real-world clinical utility of serial ctDNA analyses in patients with recurrent OC. We analyzed serial plasma …
pubmed.ncbi.nlm.nih.gov
October 31, 2025 at 5:10 PM
Reposted by Dee Sparacio
🎧🧬🎙️ Listen to Dr. Mary (Nora) Disis from @uwcvi.bsky.social where she discusses groundbreaking research on cancer prevention through vaccines & more. Many thanks to Dr. Disis & the UW CVI team for your visionary work!

#CancerResearch #SupportScience #CancerPrevention #WomenInScience #Philanthropy
Are Cancer Vaccines the Breakthrough We’ve Been Waiting For?
YouTube video by Outperform Cancer with Marybeth Gilliam
www.youtube.com
May 27, 2025 at 8:21 PM
Reposted by Dee Sparacio
At the CVI, Adam Prince works with over 30,000 frozen blood samples, some dating to the 1980s. Stored in liquid nitrogen, this living archive reveals how the immune system responds to our cancer vaccines, even decades later.

Meet Adam #OnTheCancerResearchFrontier: www.uwcvi.org/post/on-the-...
June 26, 2025 at 3:39 PM
Reposted by Dee Sparacio
🩵 September is #OvarianCancer Awareness Month.
One of the deadliest gynecologic cancers saw its federal research funding slashed from $45M to $15M.
Cancer vaccine breakthroughs are near—but progress may stall.

📢 RT to amplify. #OvarianCancer
September 12, 2025 at 5:02 PM
Reposted by Dee Sparacio
🧬 Ovarian cancer is one of the deadliest gynecologic cancers—but breakthroughs are finally within reach.

At the UW CVI, 4 promising vaccines are advancing toward a future of prevention & lasting treatment.
Hope is no longer hypothetical. It’s happening.
tinyurl.com/42xa6ya4
September 17, 2025 at 6:45 PM
It is #GCAM so I will be sharing info via blog posts.
Here is the latest about Symptoms of Ovarian Cancer. womenofteal.blogspot.com/2025/09/gcam... #gyncsm Thanks @GYNCancer for the graphic. #ASKHER #ASKME
#GCAM Symptoms of Ovarian Cancer
I follow the Foundation for Women's Cancer and loved the design of this graphic for #GCAM. I would change the hashtag #ASKHER to #ASKME.    ...
womenofteal.blogspot.com
September 4, 2025 at 7:20 PM
It's Sept 1st - Ovarian Cancer Awareness Month/ Gyn Cancer Awareness Month
My latest blog post womenofteal.blogspot.com/2025/09/sept... will start the sharing of info. What will you do this month to raise awareness and funds for research? #gyncsm #OCAM #GCAM
September is OVARIAN CANCER AWARENESS MONTH
I am not sure where the month of August went and here we are starting September. If you have followed me for any period of time you are prob...
womenofteal.blogspot.com
September 1, 2025 at 6:02 PM
Surgical and Blood-Based Minimal Residual Disease in Patients with Ovarian Cancer after First-line Therapy: Clinical Outcomes and Translational Opportunities url: aacrjournals.org/clincancerre... #gyncsm Half the women in clinical remission showed assessable min residual disease via SLL or ctDNA
Surgical and Blood-Based Minimal Residual Disease in Patients with Ovarian Cancer after First-line Therapy: Clinical Outcomes and Translational Opportunities
AbstractPurpose:. Minimal residual disease (MRD) after first-line treatment of advanced-stage ovarian cancer remains a long-standing barrier to cure. We investigated the prognostic and translational v...
aacrjournals.org
August 28, 2025 at 1:56 PM
New Global Guidelines for Treating Gestational Trophoblastic Diseases www.medpagetoday.com/reading-room...
New Global Guidelines for Treating Gestational Trophoblastic Diseases
Consensus document from four international groups
www.medpagetoday.com
August 21, 2025 at 5:00 PM
New Global Guidelines for Treating Gestational Trophoblastic Diseases www.medpagetoday.com/reading-room... #gyncsm
New Global Guidelines for Treating Gestational Trophoblastic Diseases
Consensus document from four international groups
www.medpagetoday.com
August 21, 2025 at 5:00 PM
Grateful to be celebrating 20 years since my diagnosis with stage 3b HGSOC. womenofteal.blogspot.com/2025/07/gratef
womenofteal.blogspot.com
July 29, 2025 at 7:44 PM
More Precise Treatments for Rare Uterine Tumors www.medpagetoday.com/reading-room... #gyncsm
More Precise Treatments for Rare Uterine Tumors
Advances in biological and molecular understanding of these diseases have made a difference
www.medpagetoday.com
July 17, 2025 at 9:06 PM
Reposted by Dee Sparacio
Dostarlimab Plus Chemo Prolongs Time to First, Second Subsequent Therapy Regardless of Age in Endometrial Cancer #oncology #EndometrialCancer

www.onclive.com/view/dostarl...
Dostarlimab Plus Chemo Prolongs Time to First, Second Subsequent Therapy Regardless of Age in Endometrial Cancer
After 3 years of follow-up, dostarlimab plus chemotherapy was effective and tolerable in patients aged 70 years or older with endometrial cancer.
www.onclive.com
July 11, 2025 at 7:21 PM
Reposted by Dee Sparacio
⏰Tune in this Tuesday (15th) for the next #AYACSM ( #AYACancer societal movement) #SkyChat here on @bsky.app

👋 Everyone who works in the #AYACancer field and/or who has lived experience is welcome!

#OncSky #TYACancer @scottcapozza.bsky.social @maryamlustberg.bsky.social @darcyburbage.bsky.social
July 11, 2025 at 5:44 PM
Pls share
NJ Cancer survivors/caregivers:
Members of the NJ Cancer Control Survivorship Workgroup want to understand the everyday needs of cancer survivors in New Jersey. Help us plan future programs by completing this anonymous survey.
healthsurveys.nj.gov/NoviSurvey/n/z
June 19, 2025 at 12:47 PM
June is Cancer Survivorship Month. In NJ, a variety of organizations are working together to identify and address the needs of cancer survivors. Today we share some quotes/ advice
accorg.bsky.social
cr4h.bsky.social
elixirfund.bsky.social
June 19, 2025 at 12:15 PM
June is Cancer Survivorship Month. In NJ, a variety of organizations are working together to identify and address the needs of cancer survivors. Part of our work includes raising awareness around cancer survivorship.
@accorg.bsky.social
@cr4h.bsky.social @elixirfund.bsky.social
June 17, 2025 at 1:15 PM
June is Cancer Survivorship Month. In NJ, a variety of organizations are working together to identify and address the needs of cancer survivors. Part of our work includes raising awareness around cancer survivorship. @accorg.bsky.social
@cr4h.bsky.social
@elixirfund.bsky.social
June 15, 2025 at 4:03 PM
June is Cancer Survivorship Month. In NJ, a variety of organizations are working together to identify and address the needs of cancer survivors. Part of our work includes raising awareness around cancer survivorship.
@accorg.bsky.social
@cr4h.bsky.social
@elixirfund.bsky.social
June 13, 2025 at 1:08 PM
June is Cancer Survivorship Month. In NJ, a variety of organizations are working together to identify and address the needs of cancer survivors. Part of our work includes raising awareness around cancer survivorship.
@accorg.bsky.social @cr4h.bsky.social
@elixirfund.bsky.social
June 11, 2025 at 1:42 PM
June is Cancer Survivorship Month. In NJ, a variety of organizations are working together to identify and address the needs of cancer survivors. Part of our work includes raising awareness around cancer survivorship.
@accorg.bsky.social
@cr4h.bsky.social
@elixirfund.bsky.social
June 7, 2025 at 1:57 PM